Trinity Biotech (TRIB) Finished Goods (2016 - 2025)
Trinity Biotech recorded quarterly Finished Goods of $3.6 million in Q4 2025, down 17.18% quarter-over-quarter from $4.4 million in Q4 2024, and down 17.18% year-over-year from $4.4 million in Q4 2024.
Trinity Biotech's Finished Goods history runs 7 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- In Q4 2025, Finished Goods fell 17.18% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (down 17.18% YoY), while the FY2025 annual figure was $3.6 million, down 17.18% from the prior year.
- Finished Goods came in at $3.6 million for Q4 2025 at Trinity Biotech, down from $4.4 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $4.4 million in Q4 2024 to a low of $3.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Dec 31, 2020 | 12.88 Mn |
| Dec 31, 2019 | 12.43 Mn |
| Dec 31, 2018 | 11.56 Mn |
| Dec 31, 2017 | 15.22 Mn |
| Dec 31, 2016 | 16.13 Mn |